Establishment and Comparison of Two Different Animal Models of Graves’ Orbitopathy
Translational Vision Science & Technology · 2023
DOI: 10.1167/tvst.12.6.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2023. Verfasst von Wei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Graves Ophthalmopathy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
The purpose of this study was to construct an animal model of Graves' ophthalmopathy (GO) by comparing recombinant adenovirus expressing human thyrotropin receptor A subunit (Ad-TSHR A) gene immunization and dendritic cell (DC) immunization. We evaluated the animal models that are closer to the pathology of human GO, and laid the foundation for the study of GO. Materials and Methods: Ad-TSHR A was injected intramuscularly into female BALB/c mice to induce the GO animal model. A GO animal model was constructed using TSHR combined with IFN-γ-modified primary DC immunized female BALB/c. The animal models constructed by the above two methods were evaluated in terms of ocular appearance, serology, pathology, and imaging to assess the modeling rate of the animal models, respectively.
Results
Both modeled mice exhibited increased serological indexes of free thyroxine (FT4) and TSH receptor antibodies (TRAbs) levels and decreased TSH (P < 0.01). Thyroid pathology analysis revealed the number of thyroid follicles increases, the size varies, and the follicular epithelial cells proliferate to varying degrees in a cuboidal or tall columnar pattern, with a small amount of lymphocytic infiltration visible. Adipose tissue behind the eyeball was accumulated, the muscle outside the eyeball was broken and fibrotic, and hyaluronic acid (HA) behind the eyeball was increased. The animal model of GO constructed by immunization of TSHR with IFN-γ-modified DC had a modeling rate of 60%, whereas that of Ad-TSHR A gene immunization was 72%.
Conclusions
Both gene immunization and cellular immunization can be used to construct GO models, and the modeling rate of gene immunization is higher than that of cellular immunization. Translational Relevance: In this study, two innovative methods, cellular immunity and gene immunity, were used to establish GO animal models, which improved the success rate to a certain extent. To our knowledge, this study presents the first cellular immunity modeling idea of TSHR combined with IFN-γ for the GO animal model, which provides an animal model basis for understanding the pathogenesis of GO and developing new treatment methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Cardiology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of Endocrinology, The First Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xianyang, China.
- Spine Disease Institute, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zitieren
APA
Wang, W., Zhang, J. W., Qin, Y. J., Li, H. Y., Dai, Y. X., & Li, H. (2023). Establishment and Comparison of Two Different Animal Models of Graves’ Orbitopathy. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.12.6.12
Vancouver
Wang W, Zhang JW, Qin YJ, Li HY, Dai YX, Li H. Establishment and Comparison of Two Different Animal Models of Graves’ Orbitopathy. Translational Vision Science & Technology. 2023. doi:10.1167/tvst.12.6.12
BibTeX
@article{Wang2023,
author = {Wang, Wei and Zhang, Jing-Wen and Qin, Yu-Jie and Li, Hong-Yan and Dai, Yu-Xiang and Li, Hong},
title = {Establishment and Comparison of Two Different Animal Models of Graves’ Orbitopathy},
journal = {Translational Vision Science & Technology},
year = {2023},
doi = {10.1167/tvst.12.6.12}
}
EUVIMED